and, typically of a business that continues to grow, prosper and change, the tendency is to forget to remember what these icons accomplished. Last month, two executives who were instrumental in building chain drug retailing passed away. They were radically different, yet remarkably
Walmart’s capital spending plan for next year calls for fewer new brick-and-mortar stores, and an accelerated e-commerce push. The announcement of the retailer’s spending priorities came during Walmart’s annual meeting with the investment community.
Steve Anderson joined a select group of business leaders last month when he was recognized as trade association CEO of the year.
Mylan N.V. has agreed to pay $465 million to the U.S. Department of Justice and other government agencies to resolve discrepancies about the classification of the EpiPen epinephrine auto-injector in the Medicaid Drug Rebate Program.
Target Corp. has brought its flexible format to Manhattan, opening a two-story, 45,000-square-foot store to serve Millennials and other city dwellers in the trendy neighborhood of Tribeca. The store is one of four flexible format stores that Target opened on Wednesday.
Food and drug retailer Safeway plans to open the first medically based weight-loss clinics in supermarkets in California.
Mars Inc. plans to meld its Mars Chocolate and Wrigley segments to form one global candy business unit called Mars Wrigley Confectionery. Mars said Thursday that the move comes as its has gained full ownership of Wrigley, which it acquired in 2008.
Omron Healthcare Inc. has announced the retail launch of the Omron HEAT Pain Pro, an over-the-counter medical device that uses soothing heat and TENS technology to alleviate acute muscle and joint pain.
Hershey Co. is expanding its snack lineup with Hershey’s Cookie Layer Crunch, which the company called one of the brand’s most-anticipated offerings in over 16 years.
Impacted by pricing pressure and pharmacy industry trends, Fred’s Inc. reported decreased revenue and same-store sales for September. The discount retail and pharmacy chain said Thursday that for the five weeks ended Oct. 1, sales totaled $199.9 million, down 5.5% from $211.4 million a year earlier.
Next month, Pursuant Health’s national, in-store health kiosk network will begin connecting consumers to the American Diabetes Association’s Diabetes Risk Test.
QS/1 has released an interface that integrates its workflow process with FDS Inc.’s eNGAGE patient management platform. QS/1 said Wednesday that enabling eNGAGE Alert functionality within the QS/1 NRx and PrimeCare pharmacy management systems brings more convenience and added patient detail.
Nestlé Health Science has introduced ProNourish, a nutritional drink described as the first nationally distributed product of its kind to be low in FODMAPs for people with digestive sensitivities.
Ansell has expanded its SKYN sexual wellness collection with SKYN Excite Female Stimulating Gel. The company said SKYN Excite Gel — designed and tested by women — combines high-quality ingredients which, when used with the suggested massage technique, ensure a more exciting female sexual experience.
London Drugs has delved into the customer rewards arena with the launch of its first-ever loyalty program. Called LDExtras, the rewards program comes after a successful 15-month pilot on Vancouver Island, the western Canada drug chain said Wednesday.
A rise in front-end sales hoisted revenue at Jean Coutu Group’s retail store network for the fiscal 2017 second quarter. The Canadian drug store operator also saw corporate sales climb in the quarter and topped financial analysts’ consensus forecast for adjusted earnings per share.
